| Autor: |
Davide Saporito, Eduardo Celentano, Claudia Amellone, Gabriele Zanotto, Matteo Baroni, Gennaro Miracapillo, Mauro Biffi, Valeria Calvi, Lorenzo Spighi, Antonio Curnis, Ennio Carmine Luigi Pisanò, Giovanni Rovaris, Gaetano Senatore, Fabrizio Caravati, Francesca Notarangelo, Massimiliano Marini, Francesco Solimene, Marcello Piacenti, Luca Tomasi, Luca Bontempi, Gerardo Nigro, Luca Poggio, Stefano Pedretti, Marzia Giaccardi, Paolo Pastori, Enrica Talini, Giampiero Maglia, Irene Baldassarre, Daniele Giacopelli, Alessio Gargaro, Massimo Giammaria |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2045-2322 |
| DOI: |
10.1038/s41598-024-73403-x |
| Popis: |
Abstract The historical restriction of magnetic resonance imaging (MRI) for patients with cardiac implantable electronic devices (CIEDs) has been lifted by certified MRI-conditional systems in recent years. Mixed-brand CIED systems consisting of a generator from one manufacturer and at least one lead from another manufacturer are not certified for MRI. We evaluated the temporal trend in the prevalence of mixed-brand systems in the era of MRI-conditional systems. Data were analyzed on 5853 CIEDs implanted de novo between 2012 and 2022 in 81 Italian centers linked to the nationwide Home Monitoring Expert Alliance network. The percentage of mixed-brand implants was calculated by device type (pacemaker, implantable cardioverter-defibrillator [ICD], cardiac resynchronization therapy [CRT] device) and over time. A mixed-brand system was implanted in 4.1% (95% CI, 3.6-4.6%) of analyzed patients or, by device type, in 4.5% (3.5-5.7%) of pacemaker patients, 1.1% (0.7-1.7%) of ICD patients, and 6.8% (5.7-7.9%) of CRT pacemaker/defibrillator patients (p |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
